Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy
Allergy Dec 02, 2017
Rondon C, et al. - Clinical efficacy as well as the safety of Phleum pratense subcutaneous immunotherapy (Phl-SCIT) in local allergic rhinitis (LAR) was investigated in this study. Findings demonstrated that as a treatment option for LAR to P. pratense, subcutaneous immunotherapy with depigmented polymerized allergen extracts displayed both safety and clinical efficacy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
